220 related articles for article (PubMed ID: 9130986)
21. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
22. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
23. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
Quick CM; May T; Horowitz NS; Nucci MR
Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
[TBL] [Abstract][Full Text] [Related]
24. Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?
Mang C; Birkenmaier A; Cathomas G; Humburg J
Arch Gynecol Obstet; 2017 Jun; 295(6):1435-1440. PubMed ID: 28421274
[TBL] [Abstract][Full Text] [Related]
25. FOXA1 is associated with high tumor grade, myometrial invasion and lymph node invasion in endometrial endometrioid carcinoma.
Tosun Yıldırım H; Nergiz D; Sadullahoğlu C; Süren D; Yıldırım Ş; Üreyen I; Sezer C
Ginekol Pol; 2021; 92(8):544-549. PubMed ID: 33844251
[TBL] [Abstract][Full Text] [Related]
26. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?
Silva EG; Deavers MT; Bodurka DC; Malpica A
Int J Gynecol Pathol; 2006 Jan; 25(1):52-8. PubMed ID: 16306785
[TBL] [Abstract][Full Text] [Related]
27. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
28. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
[TBL] [Abstract][Full Text] [Related]
29. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
[TBL] [Abstract][Full Text] [Related]
30. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
Zhou C; Gilks CB; Hayes M; Clement PB
Am J Surg Pathol; 1998 Jan; 22(1):113-20. PubMed ID: 9422324
[TBL] [Abstract][Full Text] [Related]
31. Advanced endometrial cancer with serous metastasis in a 17-year-old.
Cohn DE; Resnick KE; Ramirez NC; Morrison CD
Gynecol Oncol; 2006 May; 101(2):356-9. PubMed ID: 16499956
[TBL] [Abstract][Full Text] [Related]
32. Uterine papillary serous carcinoma. A clinical study.
Gitsch G; Friedlander ML; Wain GV; Hacker NF
Cancer; 1995 May; 75(9):2239-43. PubMed ID: 7712431
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
34. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
35. Grossly unremarkable cervix in endometrial carcinomas: lymphovascular space invasion and microcystic elongated and fragmented pattern may be associated with high incidence of cervical stromal involvement.
Zhang Y; Jeyachandran D; Desouki MM
Hum Pathol; 2021 Jul; 113():59-66. PubMed ID: 33933559
[TBL] [Abstract][Full Text] [Related]
36. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
37. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of intraoperative gross examination of myometrial invasion in stage I-II endometrial cancer.
Sethasathien P; Charoenkwan K; Siriaunkgul S
Asian Pac J Cancer Prev; 2014; 15(17):7061-4. PubMed ID: 25227791
[TBL] [Abstract][Full Text] [Related]
40. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
